Intravenous immunoglobulin and exchange transfusion in severe iso-immune hemolytic hyperbilirubinemia: A retrospective cohort study

Objectives To assess Intravenous Immunoglobulin (IVIG) efficacy in preventing exchange transfusion (ET) in neonates with iso-immune hemolytic disease of the newborn (HDN). Study Design A retrospective data review of 22 688 neonates admitted to the NICU of Madinah Maternity and Children’s Hospital, KSA from January 2015 to January 2025 was done. Out of them, 173 neonates ≥35 weeks with HDN at risk for ET were identified based on American Academy of Pediatrics (AAP) 2022 thresholds (74 received IVIG and 99 did not). Infants were managed according to 2004 AAP guidelines. We assessed the following outcomes: rate of ET, occurrence of rebound hyperbilirubinemia, phototherapy (PT) duration, length of hospital stay, and the need for packed red blood cells (PRBC) transfusion. The association of IVIG with outcomes was adjusted to quintiles of propensity score (PS) controlling for the likelihood of receiving IVIG. Results IVIG recipients had a greater hemolytic burden (initial hemoglobin: 14.19 vs. 16.06 g/dL, p < 0.001; reticulocyte count: 11.31% vs. 8.75%, p = 0.002; positive direct antiglobulin test: 94.6% vs. 80.8%, p = 0.008). Unadjusted analyses showed that IVIG recipients, compared to the non-IVIG group, had higher ET rates (20.27% vs. 5.05%; OR 4.78 [1.65–13.84], p = 0.002), longer PT duration, extended hospital stays, and more PRBC transfusions. However, after propensity score adjustment, no significant differences were observed for ET and PRBC transfusions. Consistent differences were retained for PT and hospital stay durations. Conclusion IVIG as an adjunct to intensive PT was not associated with a statistically significant reduction in ET rates in infants with HDN.

Authors

Institutions

Publication Details

Journal
Journal of Neonatal-Perinatal Medicine
Published
2026-11-13
DOI
https://doi.org/10.1177/19345798261506556
Primary Topic
Blood groups and transfusion
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Intravenous immunoglobulin and exchange transfusion in severe iso-immune hemolytic hyperbilirubinemia: A retrospective cohort study

Nehad Nasef, Khalid Saidy, Aziza Al‐Harbi, Abdulaziz Aljohani et al.
Journal of Neonatal-Perinatal Medicine
Blood groups and transfusion
article

Intravenous immunoglobulin and exchange transfusion in severe iso-immune hemolytic hyperbilirubinemia: A retrospective cohort study

Nehad Nasef, Khalid Saidy, Aziza Al‐Harbi, Abdulaziz Aljohani, Hanaa Almohammadi, Islam Nour, Zainab Moustafa, Mahmoud Fahmy, Fatimah Alhazmi, Abobaker Khoyate, Abdulrahman Al Faleh
article en

Abstract

Objectives To assess Intravenous Immunoglobulin (IVIG) efficacy in preventing exchange transfusion (ET) in neonates with iso-immune hemolytic disease of the newborn (HDN). Study Design A retrospective data review of 22 688 neonates admitted to the NICU of Madinah Maternity and Children’s Hospital, KSA from January 2015 to January 2025 was done. Out of them, 173 neonates ≥35 weeks with HDN at risk for ET were identified based on American Academy of Pediatrics (AAP) 2022 thresholds (74 received IVIG and 99 did not). Infants were managed according to 2004 AAP guidelines. We assessed the following outcomes: rate of ET, occurrence of rebound hyperbilirubinemia, phototherapy (PT) duration, length of hospital stay, and the need for packed red blood cells (PRBC) transfusion. The association of IVIG with outcomes was adjusted to quintiles of propensity score (PS) controlling for the likelihood of receiving IVIG. Results IVIG recipients had a greater hemolytic burden (initial hemoglobin: 14.19 vs. 16.06 g/dL, p < 0.001; reticulocyte count: 11.31% vs. 8.75%, p = 0.002; positive direct antiglobulin test: 94.6% vs. 80.8%, p = 0.008). Unadjusted analyses showed that IVIG recipients, compared to the non-IVIG group, had higher ET rates (20.27% vs. 5.05%; OR 4.78 [1.65–13.84], p = 0.002), longer PT duration, extended hospital stays, and more PRBC transfusions. However, after propensity score adjustment, no significant differences were observed for ET and PRBC transfusions. Consistent differences were retained for PT and hospital stay durations. Conclusion IVIG as an adjunct to intensive PT was not associated with a statistically significant reduction in ET rates in infants with HDN.

Journal of Neonatal-Perinatal Medicine
Mansoura University (EG), King Abdulaziz Medical City (SA)
Good health and well-being
Blood groups and transfusion
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon